Tenders Are Invited For Price registration for future and eventual acquisitions of medicines, in accordance with the specifications and quantities provided for in Annex I Term of Reference of this Notice

Price registration for future and eventual acquisitions of medicines, in accordance with the specifications and quantities provided for in Annex I Term of Reference of this Notice 1 Atropine sulfatoatropin sulfate, dosage 10 mgml, use ophthalmic solution Differentiated: Applicaility Decree 7174: non applicaility Preference margin: Non QUANTITY: 2500 supply unit: vial 500 ml2 enzocaineenzocaine, concentration 20, use differentiated topicotrata gel: Applicaility Decree 7174: Non Applicaility Preference Margin: Non Quantity: 1462 Supply Unit: Pot 1200 G3 Sodio Dydocloride Chloride, 09 Concentration, Pharmaceutical Form Injectale Solution, Additional Characteristic Closed System, Additional Characteristics 1 ag Vial Exempt Differentiated PVCtraction: Applicaility Decree 7174: Non Applicaility Preference Margin: Non Quantity: 5496Unity Supply: ag 100000 ML4 EffectiveFedrine, Sulfate Presentation, Dosage 50 mgML, Application Injectale Differentiated Treatment: Applicaility Decree 7174: Non Applicaility Preference Margin : Non Quantity: 950unidad and supply: ampoule 100 ml5 prilocaineprilocaine, composition associated with lidocaine, co